Supplementary Table S5 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma

Tanner Michael Johanns; Elizabeth A.R. Garfinkle; Katherine E. Miller; Alexandra J. Livingstone; Kaleigh F. Roberts; Lakshmi P. Rao Venkata; Joshua L. Dowling; Michael R. Chicoine; Ralph G. Dacey; Gregory Joseph Zipfel; Albert H. Kim; Elaine R. Mardis; Gavin P. Dunn

doi:10.1158/1078-0432.31085035

Supplementary Table S5 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma

2026 Open access

Read full text

Authors: Tanner Michael Johanns, Elizabeth A.R. Garfinkle, Katherine E. Miller, Alexandra J. Livingstone, Kaleigh F. Roberts, Lakshmi P. Rao Venkata, Joshua L. Dowling, Michael R. Chicoine, Ralph G. Dacey, Gregory Joseph Zipfel, Albert H. Kim, Elaine R. Mardis

+1 more

Gavin P. Dunn

DOI: 10.1158/1078-0432.31085035

Cited by: 0

Abstract

immunoSEQ resolved TCR sequences for each subject PBMCs pre- and post-NeoVax

Fields of Study & Subjects

Glioma Diagnosis and Treatment Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses

Publication details

Publication date: 19 January 2026